C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
02/1998
02/19/1998	WO1998006708A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
02/19/1998	CA2264104A1 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
02/18/1998	EP0824098A1 4-hydroxy-piperidine derivatives
02/18/1998	EP0823895A1 Fatty acid esters as bioactive compounds
02/18/1998	EP0823889A1 1,3-propane diol derivatives as bioactive compounds
02/18/1998	CN1037443C Method of prepn. of phosostigmine carbamate derivatives from physostigmine
02/17/1998	US5719286 Optical pure chemical intermediates
02/17/1998	CA2101252C Process for preparing trans-piperidine-2,5- dicarboxylates
02/11/1998	CN1173132A Dihydropyrimidines and uses thereof
02/05/1998	WO1998004559A2 Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
02/04/1998	EP0821671A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
02/03/1998	US5714504 Alkaline salts of omeprazole; antiulcer agents; magnesium omeprazole or sodium omeprazole for example
02/03/1998	CA2148616C Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid
02/03/1998	CA2098989C Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
01/1998
01/29/1998	WO1998003510A1 Azolo triazines and pyrimidines
01/28/1998	CN1171396A 4-hydroxy-piperdine derivatives
01/27/1998	US5712276 Treating nervous system disorders
01/27/1998	CA2138018C Process and intermediates for bis-aza-bicyclic anxiolytic agents
01/22/1998	WO1998002438A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/22/1998	WO1998002437A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/22/1998	CA2260061A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/22/1998	CA2260058A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/15/1998	WO1998001449A1 Novel compounds
01/15/1998	CA2260057A1 Novel compounds
01/14/1998	EP0817775A1 Quinazoline derivatives
01/14/1998	CN1170413A Process for preparing intermediates of inhibitors of enkephalinase and angiotensin coverting enzyme and intermediates thereof
01/06/1998	US5705645 Hereroaryl derivatives of monocyclic beta-lactam antibiotics
12/1997
12/31/1997	CN1036849C Method for prepn. of anti-viral compounds
12/30/1997	US5703240 Analgesics; antiinflammatory agents; nervous system disorders; psychological disorders; gastrointestinal disorders
12/30/1997	US5703109 Cyanophenyl-1,2,4-triazole derivative
12/29/1997	EP0569564B1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors
12/17/1997	EP0526543B1 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
12/11/1997	WO1997046234A1 Pharmaceutical compositions containing mesembrine and related compounds
12/10/1997	EP0674625B1 Amino-substituted pyrazoles having crf antagonistic activity
12/09/1997	US5696254 Processes for the diastereoselective synthesis of nucleoside analogues
12/09/1997	CA2028626C Process for producing 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives
12/03/1997	CN1036592C Novel method for preparation and/or purification of clavulanic acid or pharmaceutical salt or ester of same
12/03/1997	CN1036591C Carbamates of repamycin
12/02/1997	US5693818 Process for preparing pure salts of pyridinylmethyl-sulfinyl-1H-benzimidazole
12/02/1997	US5693787 Stereospecific
11/1997
11/26/1997	CN1166171A N-substituted piperidinyl bicyclic benzoate derivatives
11/25/1997	CA2101518C Neuroleptic perhydro-1h-pyrido¬1,2-a\|pyrazines
11/20/1997	WO1997043287A1 Carboline derivatives
11/19/1997	EP0806957A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir adn the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
11/19/1997	CN1165138A Block oligomers containing 2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic material
11/12/1997	EP0806426A1 Process for the preparation of clavulanic acid
11/11/1997	US5686631 Asymmetric synthesis of R and S warfarin and its analogs
11/11/1997	US5686615 Stereoselective preparation of substituted piperidines
11/11/1997	US5686457 Pyrrolopyrimidine derivatives having pharmacological activity
11/11/1997	US5686393 Arthropodicidal oxazolines and thiazolines
11/05/1997	EP0804421A1 Use of 2- (dihydro)pyrazolyl-3'-oxymethylene]-anilides as pest-control agents and fungicides
11/04/1997	US5684049 HIV-inhibiting benzeneacetamide derivatives
11/04/1997	US5684012 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/04/1997	US5684005 Phenylpyrimidine compounds as inhibitors of excitatory amino acid glutamate
10/1997
10/29/1997	EP0802916A1 Low molecular weight bicyclic thrombin inhibitors
10/29/1997	EP0802910A1 Estrogen agonists/antagonists
10/23/1997	WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997	WO1997038977A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
10/23/1997	CA2251681A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
10/22/1997	EP0801649A2 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
10/21/1997	US5679674 Analgesics
10/21/1997	CA2030433C New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases
10/21/1997	CA2016765C Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinosine monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
10/19/1997	CA2203074A1 Estrogenic agents
10/15/1997	EP0801069A1 Process for the preparation of clavulanic acid
10/15/1997	EP0800527A1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
10/14/1997	US5677448 Sulfonamidocarboxamides
10/14/1997	US5677310 Hypertensive agents, migraine
10/09/1997	WO1997036903A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
10/09/1997	CA2250209A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
10/08/1997	EP0799223A1 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
10/07/1997	US5675027 Intermediates for making 4- (2-benzothiazolyl)methylamino!-α- (3, 4-difluorophenoxy)methyl!-1-piperidineethanol
10/07/1997	US5674868 Dimethylbenzofuran and dimethylbenzopyran derivatives and their use as 5-HT3 antagonists
10/07/1997	CA2009637C Substituted-1,3-oxathiolanes with antiviral properties
10/01/1997	EP0303697B1 Derivatives of physiologically active substance k-252
10/01/1997	CN1036001C Process for producing intermediate of 4-chloro-2-thiophenecarboxylic acid and its preparation
09/1997
09/30/1997	US5672599 Compounds containing a fused bicycle ring
09/25/1997	WO1997034893A1 Pharmaceutically useful compounds
09/25/1997	WO1997034593A1 AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES
09/25/1997	CA2247814A1 Pharmaceutically useful compounds
09/24/1997	CN1160351A Compounds and methods for treatment of cancer
09/24/1997	CN1035944C Method for preparing 3-aminopiperidine derivs. and related nitrogen-contg. heterocycles
09/23/1997	US5670699 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring
09/23/1997	US5670515 Amino acid derivatives
09/23/1997	CA2069024C Processes for the diastereoselective synthesis of nucleosides
09/17/1997	CN1159808A Spiro-azabicyclic compounds useful in therapy
09/17/1997	CN1159448A Benzothiophene compounds, intermediates, compositions, and methods
09/16/1997	US5668278 Bicyclic pyrazolo compounds
09/10/1997	CN1158853A Process of preparing 5-fluoro-6-chloro-3-(4-chloro-2-thenoyl)-2-oxindole-1-carboxamide
09/10/1997	CN1158851A Process of preparing 4-chlor-2-thiophenecar-boxylic acid
09/09/1997	US5665737 Phosphodiesterase inhibitors
09/09/1997	CA1339452C Enantiomers of citalopram and derivatives thereof
09/04/1997	WO1997031640A1 Combination therapy for osteoporosis
09/03/1997	CN1158610A Quinoxaline derivatives useful in therapy
09/03/1997	CN1035765C Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds
09/02/1997	US5663357 Substituted heteroarylamides having retinoid-like biological activity
09/02/1997	US5663337 Pharmaceutically active benzoquinazoline compounds
09/02/1997	US5663320 Processes for the diastereoselective separation of nucleoside analogue synthetic intermediates
09/02/1997	CA1339421C Cephalosporin derivatives and processes for their preparation
08/1997
08/28/1997	WO1997030998A1 Azabicyclic esters of carbamic acids useful in therapy

1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 105